NASDAQ : ACHV
Achieve Life Sciences, Inc. — Financial statements
Healthcare · Biotechnology · United States
Last price 6.83 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 702.82M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Financial statements
Income statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Selling, General & Admin | 41.98M | 31.88M | 16.25M | 11.44M | 10.72M | 9.13M |
| Research & Development | 16.29M | 23.00M | 22.82M | 15.81M | 30.08M | 23.97M |
| Operating Expenses | 58.28M | 54.88M | 39.07M | 27.25M | 40.80M | 33.09M |
| Operating Income | -58.28M | -54.88M | -39.07M | -27.25M | -40.80M | -33.09M |
| Interest Expense | -994.00K | -819.00K | -2.18M | -2.85M | -1.79M | |
| Interest & Investment Income | 2.75M | 1.50M | 2.36M | 825.00K | 199.00K | 17.00K |
| Other Non Operating Income (Expenses) | -57.49M | -36.00K | -30.00K | -9.00K | 40.00K | -75.00K |
| EBT Excluding Unusual Items | -114.00M | -54.24M | -38.92M | -29.29M | -42.35M | -33.15M |
| Other Unusual Items | -35.00K | -408.00K | -904.00K | -528.00K | ||
| Pretax Income | -114.04M | -54.65M | -39.83M | -29.82M | -42.35M | -33.15M |
| Net Income | -114.04M | -54.65M | -39.83M | -29.82M | -42.35M | -33.15M |
| Net Income to Common | -114.04M | -54.65M | -39.83M | -29.82M | -42.35M | -33.15M |
| Shares Outstanding (Basic) | 63.03M | 43.59M | 32.07M | 19.83M | 10.59M | 8.12M |
| Shares Outstanding (Diluted) | 63.03M | 43.59M | 32.07M | 19.83M | 10.59M | 8.12M |
| EPS (Basic) | -1.81 | -1.25 | -1.24 | -1.50 | -4.00 | -4.08 |
| EPS (Diluted) | -1.81 | -1.25 | -1.24 | -1.50 | -4.00 | -4.08 |
| Free Cash Flow | -47.04M | -49.47M | -29.77M | -24.50M | -37.57M | -29.44M |
| Free Cash Flow Per Share | -0.75 | -1.14 | -0.93 | -1.24 | -3.55 | -3.63 |
| EBITDA | -58.05M | -54.65M | -38.84M | -27.02M | -40.56M | -32.84M |
| D&A For EBITDA | 225.00K | 228.00K | 229.00K | 228.00K | 236.00K | 250.00K |
| EBIT | -58.28M | -54.88M | -39.07M | -27.25M | -40.80M | -33.09M |
Balance sheet
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | 47.96M | 20.93M | 12.75M | 15.55M | 24.77M | 43.02M |
| Short-Term Investments | 139.34M | 15.47M | 21.61M | |||
| Cash & Short-Term Investments | 187.30M | 36.40M | 34.36M | 15.55M | 24.77M | 43.02M |
| Other Receivables | 111.00K | 105.00K | 153.00K | |||
| Receivables | 111.00K | 105.00K | 153.00K | |||
| Prepaid Expenses | 991.00K | 3.48M | 2.11M | 1.32M | 2.45M | 1.42M |
| Total Current Assets | 188.29M | 39.89M | 36.47M | 16.98M | 27.33M | 44.59M |
| Property, Plant & Equipment | 34.00K | 67.00K | 125.00K | 66.00K | 123.00K | 64.00K |
| Goodwill | 1.03M | 1.03M | 1.03M | 1.03M | 1.03M | 1.03M |
| Other Intangible Assets | 809.00K | 751.00K | 976.00K | 1.20M | 1.42M | 1.64M |
| Other Long-Term Assets | 268.00K | 49.00K | 31.00K | 92.00K | 66.00K | 183.00K |
| Total Assets | 190.44M | 41.79M | 38.63M | 19.37M | 29.97M | 47.52M |
| Accounts Payable | 606.00K | 867.00K | 1.95M | 618.00K | 1.66M | 841.00K |
| Accrued Expenses | 4.81M | 2.89M | 4.68M | 2.94M | 3.81M | 3.64M |
| Current Portion of Long-Term Debt | 7.45M | 3.70M | 16.66M | 16.07M | ||
| Current Portion of Leases | 36.00K | 61.00K | 55.00K | 63.00K | 58.00K | 69.00K |
| Other Current Liabilities | 184.75M | 1.56M | 528.00K | |||
| Total Current Liabilities | 197.66M | 9.08M | 6.68M | 20.81M | 21.60M | 4.55M |
| Long-Term Debt | 7.46M | 11.19M | 9.84M | 14.92M | ||
| Long-Term Leases | 5.00K | 66.00K | 6.00K | 69.00K | 4.00K | |
| Other Long-Term Liabilities | 1.15M | |||||
| Total Liabilities | 205.12M | 20.27M | 17.73M | 20.82M | 21.67M | 19.47M |
| Common Stock | 170.00K | 121.00K | 103.00K | 90.00K | 87.00K | 79.00K |
| Additional Paid-In Capital | 330.40M | 281.61M | 226.34M | 164.21M | 144.15M | 121.55M |
| Retained Earnings | -345.16M | -260.23M | -205.58M | -165.75M | -135.94M | -93.59M |
| Comprehensive Income & Other | -88.00K | 10.00K | 31.00K | 4.00K | 4.00K | 4.00K |
| Shareholders' Equity | -14.68M | 21.52M | 20.90M | -1.45M | 8.30M | 28.04M |
| Total Liabilities & Equity | 190.44M | 41.79M | 38.63M | 19.37M | 29.97M | 47.52M |
| Total Debt | 14.95M | 14.96M | 9.96M | 16.73M | 16.20M | 14.99M |
| Net Cash (Debt) | 172.35M | 21.45M | 24.40M | -1.19M | 8.57M | 28.03M |
| Net Cash Per Share | 2.73 | 0.49 | 0.76 | -0.06 | 0.81 | 3.45 |
| Filing Date Shares Outstanding | 102.90M | 53.24M | 34.69M | 34.25M | 17.93M | 9.46M |
| Total Common Shares Outstanding | 102.72M | 53.23M | 34.69M | 21.17M | 17.90M | 9.45M |
| Working Capital | -9.36M | 30.81M | 29.79M | -3.83M | 5.73M | 40.04M |
| Book Value Per Share | -0.14 | 0.40 | 0.60 | -0.07 | 0.46 | 2.97 |
| Tangible Book Value | -16.52M | 19.73M | 18.89M | -3.68M | 5.85M | 25.37M |
| Tangible Book Value Per Share | -0.16 | 0.37 | 0.54 | -0.17 | 0.33 | 2.68 |
| Machinery | 142.00K | 142.00K | ||||
| Leasehold Improvements | 25.00K | 25.00K |
Cash flow statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Net Income | -114.04M | -54.65M | -39.83M | -29.82M | -42.35M | -33.15M |
| Depreciation & Amortization | 225.00K | 228.00K | 229.00K | 228.00K | 236.00K | 250.00K |
| Other Amortization | 48.00K | 52.00K | 23.00K | |||
| Stock-Based Compensation | 9.91M | 8.76M | 5.33M | 3.44M | 3.27M | 2.19M |
| Other Operating Activities | 57.51M | 408.00K | 2.07M | 2.45M | 1.20M | 41.00K |
| Change in Accounts Payable | -612.00K | -1.08M | 1.33M | -1.04M | 799.00K | 509.00K |
| Change in Other Net Operating Assets | 619.00K | -3.18M | 1.08M | 264.00K | -720.00K | 725.00K |
| Operating Cash Flow | -47.02M | -49.47M | -29.77M | -24.48M | -37.57M | -29.44M |
| Capital Expenditures | -19.00K | -3.00K | -21.00K | |||
| Sale of Property, Plant & Equipment | 4.00K | 4.00K | ||||
| Investment in Securities | -135.29M | 6.11M | -21.58M | |||
| Other Investing Activities | -1.00K | -1.00K | ||||
| Investing Cash Flow | -135.47M | 6.11M | -21.58M | -21.00K | ||
| Long-Term Debt Issued | 5.00M | 9.81M | 14.93M | |||
| Total Debt Issued | 5.00M | 5.00M | 9.81M | 14.93M | ||
| Long-Term Debt Repaid | -18.11M | |||||
| Total Debt Repaid | -18.11M | |||||
| Net Debt Issued (Repaid) | 5.00M | 5.00M | -8.29M | 14.93M | ||
| Issuance of Common Stock | 173.78M | 46.53M | 56.94M | 15.53M | 19.36M | 21.68M |
| Repurchase of Common Stock | -114.00K | -220.00K | -47.00K | |||
| Other Financing Activities | -30.00K | |||||
| Financing Cash Flow | 178.78M | 51.53M | 48.53M | 15.28M | 19.32M | 36.61M |
| Foreign Exchange Rate Adjustments | 5.00K | 3.00K | -3.00K | 3.00K | -1.00K | |
| Net Cash Flow | -3.70M | 8.18M | -2.82M | -9.22M | -18.25M | 7.17M |
| Free Cash Flow | -47.04M | -49.47M | -29.77M | -24.50M | -37.57M | -29.44M |
| Free Cash Flow Per Share | -0.75 | -1.14 | -0.93 | -1.24 | -3.55 | -3.63 |
| Levered Free Cash Flow | 156.32M | -28.46M | -18.34M | -15.43M | -23.11M | -17.06M |
| Unlevered Free Cash Flow | 156.90M | -28.00M | -17.00M | -13.64M | -21.99M | -17.06M |
| Change in Working Capital | 7.00K | -4.27M | 2.41M | -778.00K | 79.00K | 1.23M |
Ratios
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Market Capitalization | 702.82M | 264.57M | 121.05M | 87.20M | 43.85M | 73.55M |
| Enterprise Value | 530.47M | 226.42M | 87.99M | 83.56M | 41.44M | 40.33M |
| Last Close Price | 6.83 | 4.97 | 3.52 | 4.12 | 2.45 | 7.78 |
| PB Ratio | 12.29 | 5.79 | -60.22 | 5.28 | 2.62 | |
| P/TBV Ratio | 13.41 | 6.41 | 7.49 | 2.90 | ||
| Debt / Equity Ratio | -1.02 | 0.69 | 0.48 | -11.55 | 1.95 | 0.54 |
| Net Debt / Equity Ratio | 11.74 | -1.00 | -1.17 | -0.82 | -1.03 | -1.00 |
| Net Debt / EBITDA Ratio | 2.97 | 0.39 | 0.63 | -0.04 | 0.21 | 0.85 |
| Net Debt / FCF Ratio | 3.66 | 0.43 | 0.82 | -0.05 | 0.23 | 0.95 |
| Quick Ratio | 0.95 | 4.01 | 5.14 | 0.75 | 1.15 | 9.49 |
| Current Ratio | 0.95 | 4.39 | 5.46 | 0.82 | 1.26 | 9.80 |
| Return on Equity (ROE) | -844.99% | -257.67% | -409.51% | -869.88% | -233.04% | -101.49% |
| Return on Assets (ROA) | -29.21% | -85.30% | -84.19% | -69.03% | -65.82% | -47.11% |
| Return on Capital Employed (ROCE) | 807.40% | -167.80% | -122.30% | 1,889.70% | -487.30% | -77.00% |
| Earnings Yield | -26.49% | -20.66% | -32.90% | -34.19% | -96.58% | -45.07% |
| FCF Yield | -6.69% | -18.70% | -24.59% | -28.09% | -85.68% | -40.03% |
| Buyback Yield / Dilution | -82.32% | -35.93% | -61.75% | -87.17% | -30.46% | -198.64% |